Paul C. Lee, M.D.

Thoracic Surgery
Paul Lee

We have seen a rapid growth of thoracic surgery over the past several years at Weill Cornell Medical Center. Major lung and esophageal resections continue to increase annually, while the operative mortality remains one of the lowest in the nation.This is made possible by a dedicated team of surgeons, anesthesiologists, nurses, pulmonary specialists, medical oncologists, and radiation oncologists.  At Weill Cornell, we strive to provide the best and the most complete care to every patient.

Dr. Paul C. Lee is a Professor of Cardiothoracic Surgery and an Attending Surgeon in the Division of Thoracic Surgery at the New York Presbyterian-Weill Cornell Medical Center.  Dr. Lee is also the Chief of the Thoracic Surgery Division and  the Vice Chairman of the Department of the Cardiothoracic Surgery at New York Hospital Queens.

Dr. Lee completed his medical school training at Johns Hopkins University School of Medicine. He carried out his general surgical residency at the University of Pittsburgh Medical Center and his cardiothoracic surgery residency at the New York Presbyterian Hospital-Cornell University Medical Center and the Memorial-Sloan Kettering Cancer Center. During this time, Dr. Lee received additional training in minimally invasive thoracoscopic surgery at the University of Pittsburgh Medical Center.

Dr. Paul C. Lee has published more than eighty peer-reviewed articles and has presented in many national meetings in the fields of cardiopulmonary physiology, molecular cell biology and thoracic oncology.

Dr. Lee has a special interest in the treatment of lung and esophageal cancers, as well as in the treatment of gastroesophageal reflux disease and achalasia.

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Health Plan
  • CIGNA
  • Elderplan
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Fidelis Care
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Plus - Amerigroup
  • Medicare [Medicare]
  • NY Hotel Trades Council (Local 6) [PPO]
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • Rockefeller University - CoreSource
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • United Health Care

Publications

REFEREED ARTICLES

1. Zehr KJ, Herskowitz A, Lee PC, Poston RS, Gillinov AM, Baumgartner WA. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection. J Heart Lung Transplant 1993;12:837-845.

2. Zehr KJ, Lee PC, Poston RS, Gillinov AM, Hruban RH, Cameron DE. Protection of the internal mammary artery pedicle with polytetrafluoroethylene membrane. J Cardiac Surg 1993;8:650-655.

3. Zehr KJ, Herskowitz A, Lee PC, Kumar P, Gillinov AM, Baumgartner WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994;57:900-906.

4. Zehr KJ, Lee PC, Poston RS, Gillinov AM, Greene PS, Cameron DE. Two decades of coronary artery bypass graft surgery in young adults. Circulation 1994;90:II133-139.

5. Zehr KJ, Poston RS, Lee PC, Uthoff K, Kumar P, Cho PW, Gillinov AM, Redmond JM, Winkelstein JA, Herskowitz A. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 1995;59:328-335.

6. Uthoff K, Zehr KJ, Lee PC, Low RA, Baumgartner WA, Cameron DE, Stuart RS. Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation. Ann Thorac Surg 1995;59:7-13.

7. Lee PC, Salyapongse AN, Bragdon GA, Shears LL, Watkins SC, Edington HDJ, Billiar TR. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999;277:H1600-1608.

8. Lee PC, Rhee RY, Gordon RY, Fung JJ, Webster MW. Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg 1999;189:483-490.

9. Lee PC, Kibbe MR, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide mediates growth factor-stimulated angiogenesis. Surgical Forum 1999;50:469-471.

10. Lee PC, Wang ZL, Qian S, Watkins SC, Lizonova A, Kovesdi I, Tzeng E, Simmons RL, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation 2000;69:1186-1192.

11. Kanno S*, Lee PC*, Zhang Y, Ho C, Griffith BP, Shears LL, Billiar TR. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 2000;101:2742-2748. * Shared co-authorship.

12. Lee PC, Wang ZL, Mahidhara R, Qian S, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac rejection. Surgical Forum 2000;51:357-359.

13. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis and upregulates avb3 integrin expression on endothelial cells. Microvascular Research 2000;60:269-280.

14. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J Thorac Cardiovasc Surg 2000;120:923-934.

15. Lee PC, Mateo RB, Clarke MR, Brown ML, Carty SE. Parathyromatosis: a cause for recurrent hyperparathyroidism. Endocrine Practice 2001;7:189-192.

16. Vorp DA, Lee PC, Wang DHJ, Makaroun MS, Nemoto EM, Ogawa S, Webster MW. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 2001;34:291-299.

17. Kanno S, Wu YL, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001;104:934-938.

18. Kanno S, Wu YL, Lee PC, Billiar TR, Ho C. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expressions in Monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 2001;104:945-950.

19. Port JL, Kent M, Korst RJ, Lee PC, Levin MA, Flieder D, Altorki NK.

Surgical resection for lung cancer in the octogenarian. Chest 2004; 126(3):733-8.

20. Korst RJ, Gold HT, Kent MS, Port JL, Lee PC, Altorki NK. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs. Journal of Thoracic & 5Cardiovascular Surgery 2005;129:652-60.

21. Port JL, Korst RJ, Lee PC, Levin MA, Becker DE, Keresztes R, Altorki NK. Surgical resection for residual N2 disease after induction chemotherapy. Ann Thorac Surg 2005; 79:1686-1690.

22. Korst RJ, Port JL, Lee PC, Altorki NK. Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma. Ann Thorac Surg 2005; 80:1185-90.

23. Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. Ann Thorac Surg 2005; 80:1215-23.

24. Port JL, Andrade RS, Levin MA, Korst RJ, Lee PC, Becker DE, Altorki NK. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less. J Thorac Cardiovasc Surg 2005; 130:1611-5.

25. Korst RJ, Kansler AL, Port JL, Lee PC, Karem Y, Altorki NK. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma. Ann Thorac Surg 2006; 82:480-4.

26. Korst RJ, Kansler AL, Port JL, Lee PC, Altorki NK. Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann Thorac Surg 2006; 82:1009-15.

27. Lee PC, Korst RJ, Port JL, Kerem Y, Kansler A, Altorki NK. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. J Thorac Cardiovasc Surg 2006;132(6):1382-88.

28. Kreisel D, Arora N, Weisenberg SA, Saqi A, Krupnick AS, MDa, Demetriades AM, Iakovou C, Conetta R, Lee PC. Tuberculosis presenting as an endobronchial mass. J Thorac Cardiovasc Surg 2007; 133:582-584.

29. Port JL, Korst RJ, Lee PC, Kansler AL, Kerem Y, Altorki NK. Surgical resection for multifocal (T4) non-small cell lung cancer: Is the T4 designation valid? Ann Thorac Surg 2007; 83:397-401.

30. Kim AW, Korst RJ, Port JL, Altorki NK, Lee PC. Giant cavernous hemangioma of the distal esophagus treated with esophagectomy. J Thorac Cardiovasc Surg 2007; 133: 1665 - 1667.

31. Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altork NK. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007; 84:177-181.

32. Robinson DA, Lee, PC. Middle lobe syndrome: Case report and review of literature. Clin Pulm Med 2007; 14:244-248.

33. Port JL, Lee PC, Korst RJ, Liss Y, Meherally D, Christos P, Mazumdar M, and Altorki NK. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 2007; 84:393-400.

34. Huston JM, King H, Maresh A, Liska D, Port JL, Altorki NK, Lee PC. Hernia of Morgagni: case report. J Thorac Cardiovasc Surg 2008; 135(1):212-3.

35. Sica G, Vazquez MF, Altorki N, Port J, Lee PC, Liu Y, Hyjek E, Saqi A. PAX-5 expression in pulmonary neuroendocrine neoplasms: Its usefulness in surgical and fine-needle aspiration biopsy specimens. Am J Clin Pathol. 2008; 129(4):556-62.

36. Wagner PL, Tam W, Lau PY, Port JL, Paul S, Altorki NK, Lee PC. Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: A case report and literature review. J Thorac Cardiovasc Surg 2008; 135:957-8.

37. Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg 2008; 247(3):434-9.

38. Servais E, Paul S, Port JL, Altorki NK, Lee PC. Carcinoid tumor nested within a bronchogenic cyst. J Thorac Cardiovasc Surg 2008; 136(1):227-8.

39. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, Mazumdar M. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 2008; 248(2):221-6.

40. Sharma B, Agarwal S, Karbowitz S, Gumpeni R, Lee PC, Paul S. A man with end-stage renal disease and dyspnea. Journal of Respiratory Diseases 2008; 29(8):302-306.

41. Abrams JA, Lee PC, Port JL, Altorki NK, Neuqut AI. Cigarette smoking and risk of lung metastasis from esophageal cancer. Cancer Epidemiol Biomarkers Prev 2008;17(10):2707-13.

42. John BK, Dang NC, Hussain SA, Yang GC, Cham MD, Yantiss R, Joseph AS, Giashuddin SM, Lee PC, Fleming R, Somnay K. Multifocal granular cell tumor presenting as an esophageal stricture. J Gastrointest Cancer. 2008;39(1-4):107-13.

43. Sharma B, Sha K, Lee PC. A 75-year-old man with significant bleeding after transbronchial biopsy. Platelets 2008;19(7): 559-560.

44. Agarwal S, Sharma B, Sabayev V, Lee PC, Gumpeni R. Primary synovial sarcoma presenting as an endobronchial mass. Journal of Respiratory Diseases 2008; 29(11):435-437.

45. Sica G, Wagner PL, Altorki N, Port J, Lee PC, Vazquez MF, Saqi A. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med. 2008;132(12):1889-95.

46. John BK, Luo JJ, Lee PC, Fleming RA. Choriocarcinoma: an unusual case of hemoptysis. J Resp Diseases. 2008;(29)10:376-81.

47. Stiles BM, Servais EL, Lee PC, Port JL, Paul S, Altorki NK. Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: The problem of understaging. J Thorac Cardiovasc Surg 2009;137:13-9.

48. Paul S, Lee, PC, Altorki NK, Stiles BM, Port JL. Partial upper sternotomy for

anterosuperior mediastinal surgery: An institutional experience. Ann Surg Oncol 2009; 16(4) 1039-42.

49. Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, Rengifo T, Sica GL, Port JL, Lee PC, Paul S, Altorki NK, Saqi A. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg 2009;137(3):615-21.

50. Paul S, Altorki NK, Stiles BM, Port JL, Lee PC. A case of severe heartburn. Ann Thorac Surg 2009;87:1959.

51. Paul S, Altorki NK, Port JL, Stiles BM, Lee PC. Surgical management of chylothorax. Thorac Cardiov Surg 2009; 57: 226-228.

52. Paul S, Altorki NK, Stiles BM, Port JL, Lee PC. Images in cardiothoracic surgery. A case of severe heartburn. Ann Thorac Surg 2009; 87(6):1959.

53. Lee PC, Port JL, Paul S, Stiles BM, Altorki NK. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Ann Thorac Surg 2009;88(1):186-92; discussion 192-3.

54. Gulkarov I, Paul S, Altorki NK, Lee PC. Use of Amplatzer device for endobronchial closure of bronchopleural fistulas. Interact Cardiovasc Thorac Surg 2009; 9: 901-902.

55. Lee BE, Port JL, Stiles BM, Saunders J, Paul S, Lee PC, Altorki NK. TNM stage is the most important determinant of survival in metachronous lung cancer. Ann Thorac Surg 2009;88(4):1100-5.

56. Stiles BM, Christos P, Port JL, Lee PC, Paul S, Saunders J, Altorki NK. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer. J Thorac Cardiovasc Surg 2010; 139: 387-394.

57. Paul S, Altorki NA, Sheng S, Lee PC, Harpole DH, Onaitis MW, Stiles BM, Port JL, D'Amico TA. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010; 139: 366 - 378.

58. Sharma B, Reddy M, Lee PC, Cortes G, Gumpeni R. An unusual clinical presentation of a rare renal tumor. Nephrol Dial Transplant 2010; 25(5):1713-5.

59. Altorki N, Lane ME, Bauer T, Lee PC, Guarino MJ, Pass H, Felip E, Peylan-Ramu N, Gurpide A, Grannis FW, Mitchell JD, Tachdjian S, Swann RS, Huff A, Roychowdhury DF, Reeves A, Ottesen LH, Yankelevitz DF. Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. J Clin Oncol 2010; 28(19): 3131-7.

60. Stiles BM, Mirza F, Port JL, Lee PC, Paul S, Christos P, Altorki NK. Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer. Ann Thorac Surg. 2010; 90(6):1805-11; discussion 1811.

61. Paul S, Mirza F, Port JL, Lee PC, Stiles BM, Kansler AL, Altorki NK. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors. J Thorac Cardiovasc Surg. 2011;141(1):48-58.

62. Nguyen AB, Lee PC, Paul S. Crepitus: an uncommon complication of a common procedure. Ann Thorac Surg. 2011 Apr;91(4):e63.

63. Lee PC, Mirza FM, Port JL, Stiles BM, Paul S, Christos P, Altorki NK. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg 2011 May;141(5):1196-206. Epub 2011 Mar 12

64. Altorki NK, Christos P, Port JL, Lee PC, Mirza F, Spinelli C, Keresztes R, Beneck D, Paul S, Stiles BM, Zhang Y, Schrump DS. Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial. J Thorac Oncol. 2011 Jun;6(6):1121-7.

65. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol. 2011 May6. [Epub ahead of print]

66. Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease. Ann Thorac Surg. 2011 Aug;92(2):491-8. Epub 2011 Jun 24.

67. Chand M, Mann JM, Sabayev V, Luo JJ, Cohen PR., Travis WD, Lee PC, Paul S. Endotracheal myoepithelioma. Chest 2011 Jul;140(1):242-4.

68. Paul S, Mirza FM, Nasar A, Port JL, Lee PC, Stiles BM, Nguyen AB, Sedrakyan A, Altorki NK. Prevalence, outcomes, and a risk-benefit analysis of diaphragmatic hernia admissions: An examination of the National Inpatient Sample database. J Thorac Cardiovasc Surg. 2011 Oct;142(4):747-54. Epub 2011 Jul 30.

69. Parashar B, Wernicke, AG, Pavese A, Prabhsimranjot S, Trichter S, Sabbas A, Kutler DI, Kuhel W, Port JL, Lee PC, Dattatreyudu N, Clifford Chao KS. Cesium-131 permanent seed brachytherapy: Dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff. American Brachytherapy Society 2011 Jun 1. [Epub ahead of print].

70. Port JL, Mirza FM, Lee PC, Paul S, Stiles BM, Altorki NK. Lobectomy in octogenarians with non-small cell lung cancer: Ramifications of increasing life expectancy and the benefits of minimally invasive surgery. Ann Thorac Surg 2011 Dec;92(6):1951-7 Epub 2011 Oct 7.

71. Stiles BM, Mirza F, Towe CW, Ho VP, Port JL, Lee PC, Paul S, Yankelevitz D, Altorki NK. Cumulative radiation dose from medical imaging procedures in patients undergoing resection for lung cancer. Ann Thorac Surg. 2011 Oct;92(4):1170-9. Epub 2011 Jul 13.

72. Paul S, Nasar A, Port JL, Lee PC, Stiles BC, Nguyen AB, Altorki NK, Sedrakyan A. Comparative Analysis of Diaphragmatic Hernia Repair Outcomes Using the Nationwide Inpatient Sample Database. Arch Surg. 2012 Mar 19. [Epub ahead of print]

73. Stiles BM, Nasar A, Mirza FA, Lee PC, Paul S, Port JL, Altorki NK. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. Eur J Cardiothorac Surg. 2012 Apr 4. [Epub ahead of print]

CHAPTERS & REVIEW ARTICLES

1. Lee PC, Shears LL, Billiar TR. Role of inducible nitric oxide synthase in transplant arteriosclerosis. Clin Exp Pharmacol Physiol 1999;26:1013-1015.

2. Kibbe MR*, Lee PC*, Billiar TR, Tzeng E. Nitric oxide synthase gene transfer. In: Ignarro LJ, editor. Nitric oxide: Biology and pathobiology. 1st ed. Academic Press 2000:503-524.

3. Lee PC, Altorki NK. Surgery techniques: en bloc esophagectomy. In: Jobe BA, Thomas CR, Hunter JG, editors. Esophageal Cancer: Principles and Practice. Demos Medical Publishing 2009: 591-598.

4. Port JL, Lee PC, Altorki NK. Extended resection for esophageal carcinoma. In: Shields TW, Locicero J III, Reed CE, Feins RH, editors. General Thoracic Surgery, 7th edition. Lippincott Williams & Wilkins 2009: 1759-1770.

5. Lee PC, Altorki NK. Radical en bloc esophagectomy. In: Sugarbaker DJ, editor. Adult Chest Surgery, 1st edition. McGraw Hill. 2009:163-170.

6. Lee PC, Altorki NK. Extent of resection for stage I lung cancer. In:Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi AT, editors. Principles and Practice of Lung Cancer, 4th edition. Lippincott Williams & Wilkins 2010: 459-465.

* Shared co-authorship.

PUBLISHED ABSTRACTS

1. Lee PC, Billiar TR, Watkins SC, Griffith BP, Shears LL. Endothelial nitric oxide synthase (eNOS) is not required for vascular endothelial growth factor (VEGF) induced angiogenesis. FASEB Journal 1999;13:A1007.

2. Lee PC, Rhee RY, Gordon RY, Webster MW, Fung JJ. Management of splenic artery aneurysms (SAA) in liver transplant patients. Liver Transplantation and Surgery 1999;5:C41.

3. Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Gleixner SL, Watkins SC, Griffith BP, Billiar TR, Shears LL. Nitric oxide induces angiogenesis by upregulation of vitronectin expression in endothelial cells. Circulation, Suppl 1999;100:I405.

4. Kanno S, Zhang Y, Ho C, Shears LL, Griffith BP, Billiar TR, Lee PC. The effects of nitric oxide on myocardial ischemia reperfusion injury in mice. Circulation, Suppl 1999;100:I112.

5. Lee PC, Wang ZL, Watkins SC, Qian S, Billiar TR, Shears LL. Endothelial nitric oxide synthase protects allografts from transplant vasculopathy. J Surg Research 1999;86:279.

6. Lee PC, Billiar TR, Watkins SC, Griffith BP, Shears LL. Endothelial nitric oxide synthase (eNOS) is not required for basic fibroblast growth factor (bFGF) induced angiogenesis in vivo. Journal of Vascular and Interventional Radiology 1999;10(7):987.

7. Lee PC, Wang ZL, Mahidhara R, Qian S, Watkins SC, Griffith BP, Billiar TR, Shears LL. Inducible nitric oxide synthase attenuates acute cardiac rejection. J Am Coll Surg 2000;191 (No.4 Suppl):S98-S99.

8. Wang ZL, Zhang Y, Hu T, Billiar TR, Lee PC. Myocardial assessment by MRI in murine heterotopic heart transplant models. FASEB Journal 2001;15:A1007.

9. Altorki N, Guarino M, Lee P, Pass HI, Filip E, Bauer T, Roychowdhury D, Zaks T, Ottesen L, Yankelevitz D. Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study. Journal of Clinical Oncology 2008;26(15Suppl Part I):411s.

10. Sharma BK, Reddy M, Lee PC, Gumpeni R. An interesting presentation of a rare renal tumor. Chest Meeting Abstracts 2008;134:C27001.

11. Salehmohamed MA, Reddy K, Lee PC, Gumpeni R. Peripheral arterial tumor emboli from lung cancer. Chest Meeting Abstracts 2008; 134:C39001.

12. Stiles BM, Mirza F, Chiu Y, Port JL, Lee PC, Paul S, Altorki NK. Evaluation of neoadjuvant "window of opportunity" trials with targeted therapy in patients with surgically resectable non-small cell lung cancer. Journal of Clinical Oncology 2010;28(15Suppl Part I):529s.

13. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of posto-perative disease recurrence in esophageal cancer. Gastroenterology 2010;138 (5):S885-886.

Honors and Awards

1987 Westinghouse Science Research Semi-finalist

1988-1991 Harvard College Scholarship

1993 Alpha Omega Alpha Research Fellowship Award

1998-2000 Thoracic Surgery Foundation Research Fellowship

1999 First Place Winner in 7th Annual Fellows' Research Day, American Heart Association Western PA District

2000 First Place Winner of the 19th Annual William J. von Liebig Foundation Residents & Fellows Award

2001 Doris B. Maxwell Research Award, University of Pittsburgh

2006 Castle Connolly Top Doctor in New York Metropolitan Area

2007 Castle Connolly Top Doctor in New York Metropolitan Area

2008 Castle Connolly Top Doctor in New York Metropolitan Area

2008 America's Top Surgeons by Consumers' Research Council of America

2009 Castle Connolly Top Doctor in New York Metropolitan Area

2009 America's Top Surgeons by Consumers' Research Council of America

2010 New York Super Doctor by New York Times Magazine

2010 Castle Connolly Top Doctor in New York Metropolitan Area